47 results
Page 2 of 3
8-K
EX-99.1
sm68rammvcw83wsigr
11 Jan 21
Net cash used for the fourth quarter 2020 of $3.7 million, compares favorably to previously announced guidance of $4M
8:17am
8-K
EX-99.1
icxrohrnbpwrl
12 Nov 20
Revenue growth of 44% over the second quarter of 2020 and 58% over the third quarter of 2019
4:08pm
8-K
EX-99.1
6veje3p9edkmfeu m5t
13 Oct 20
Third quarter 2020 Revenue expected to exceed $1 million, representing an increase of greater than 35% sequentially and greater than 50% over Q3 2019
8:10am
8-K
EX-99.1
nu57fzrz 0hn
13 Aug 20
Further strengthened balance sheet and reduced quarterly cash burn
4:11pm
8-K
EX-99.1
7qbftg4
31 Jul 20
Initial distribution to hospitals and patients expected to begin on July 31st
5:09pm
8-K
EX-99.1
uhnxtvnfy
15 Jul 20
Regulation FD Disclosure
5:15pm
8-K
EX-99.1
16zz9g
13 Jul 20
Other Events
8:33am
8-K
EX-99.1
1ojbwhmiayb8 45mjx
14 May 20
Generated first quarter revenue of $734,000
4:11pm
8-K
EX-99.1
duktow0p7wn o8
1 May 20
Other Events
4:30pm
8-K
EX-99.1
1musy
20 Apr 20
First Quarter 2020 Guidance
5:00pm
8-K
EX-99.1
t1zldnxg0fv2k qwe84
2 Apr 20
Other Events
4:30pm
424B5
h0rmf
30 Mar 20
Prospectus supplement for primary offering
8:10am
8-K
EX-99.1
01r3c3 81vgsycaw
26 Mar 20
John Gandolfo, Tom Patton and Peter Cuneo to join the Board, adding significant medical technology
5:02pm
8-K
EX-99.2
uaqi0 swiai
13 Jan 20
Regulation FD Disclosure
8:37am
8-K
EX-99.1
mvv4fwps rg91j5
13 Jan 20
Regulation FD Disclosure
8:37am
8-K
EX-99.1
3818xcj
27 Dec 19
Departure of Directors or Certain Officers
5:05pm
DEF 14A
qmu5x
30 Apr 19
Definitive proxy
4:45pm
10-K
js71 khtmtj8j2dfdn
28 Mar 19
Annual report
11:54am